Skip to content

Research on Blockchain-enabled Home Care Systems in Disabled Cancer Patients: Focusing on the Dual Needs of Caregivers and Patients

Research on Blockchain-enabled Home Care Systems in Disabled Cancer Patients: Focusing on the Dual Needs of Caregivers and Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117698
Enrollment
Unknown
Registered
2026-01-27
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disabled Cancer Patients

Interventions

Control Group:Regular telephone follow-up (once a month, only inquiring about the condition and medication use)
Intervention Group:Multi-dimensional intervention of blockchain-enabled family online hospitals (including monthly video follow-ups, wechat mini-program/group guidance, and multi-disciplinary group Q&

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily sign the informed consent form; 2. Aged 40–70 years old; 3. No gender restriction; 4. Pathologically confirmed as cancer patients with an Activity of Daily Living (ADL) Scale score <= 60 points (moderate to severe dependence); 5. Expected survival period of one year or more; 6. Normal communication ability and willingness to cooperate with the relevant evaluations and follow-ups of the study.

Exclusion criteria

Exclusion criteria: 1. Conscious disturbance with unstable condition; 2. Complicated with severe organic diseases, such as failure of heart, liver, kidney and other organ functions; 3. Presence of anticipatory grief and refusal to participate in this study; 4. Assessed by researchers as unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
The ability to perform activities of daily living six months after discharge;

Secondary

MeasureTime frame
Scores of each dimension of Quality of life (SF-36) 6 months after discharge;The rates of missed doses, incorrect doses of medication and the incidence of side effects of grade 3 and above chemotherapy/targeted therapy at 3 months and 6 months after discharge;The incidence of stage II and above pressure ulcers and deep vein thrombosis (DVT) at 3 months and 6 months after discharge;Anxiety (SAS) and depression (SDS) scores 6 months after discharge;

Countries

China

Contacts

Public ContactYao Zhiqi

Southern Medical University Southern Hospital

yaozqsmu@163.com+86 20 62787150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026